Related references
Note: Only part of the references are listed.Inhibition of platelet activation prevents the P-selectin and integrin-dependent accumulation of cancer cell microparticles and reduces tumor growth and metastasis in vivo
Soraya Mezouar et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Microparticle association and heterogeneity of tumor-derived tissue factor in plasma: is it important for coagulation activation?
M. Davila et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Extracellular DNA in Pancreatic Cancer Promotes Cell Invasion and Metastasis
Fushi Wen et al.
CANCER RESEARCH (2013)
Neutrophil histone modification by peptidylarginine deiminase 4 is critical for deep vein thrombosis in mice
Kimberly Martinod et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Circulating microparticle tissue factor, thromboembolism and survival in pancreaticobiliary cancers
Anubha Bharthuar et al.
THROMBOSIS RESEARCH (2013)
Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer
Jian-Guo Wang et al.
BLOOD (2012)
Tumor Grade Is Associated With Venous Thromboembolism in Patients With Cancer: Results From the Vienna Cancer and Thrombosis Study
Jonas Ahlbrecht et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo
Marie-Luise von Bruehl et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Neutrophil extracellular traps promote deep vein thrombosis in mice
A. Brill et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients
J. Thaler et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Somatic LMCD1 mutations promoted cell migration and tumor metastasis in hepatocellular carcinoma
C-Y Chang et al.
ONCOGENE (2012)
Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis
Melanie Demers et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Anticancer treatment and thrombosis
Anna Falanga et al.
THROMBOSIS RESEARCH (2012)
Anthracycline treatment of the human monocytic leukemia cell line THP-1 increases phosphatidylserine exposure and tissue factor activity
Jeremiah C. Boles et al.
THROMBOSIS RESEARCH (2012)
von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models
Alexander Brill et al.
BLOOD (2011)
Histones induce rapid and profound thrombocytopenia in mice
Tobias A. Fuchs et al.
BLOOD (2011)
Pancreatic cancer cell and microparticle procoagulant surface characterization: involvement of membrane-expressed tissue factor, phosphatidylserine and phosphatidylethanolamine
Katherine R. Yates et al.
BLOOD COAGULATION & FIBRINOLYSIS (2011)
Breast cancer chemotherapy induces the release of cell-free DNA, a novel procoagulant stimulus
L. L. Swystun et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
In vivo Bioimaging as a Novel Strategy to Detect Doxorubicin-Induced Damage to Gonadal Blood Vessels
Hadas Bar-Joseph et al.
PLOS ONE (2011)
Cancer-associated thrombosis Introduction
A. K. Kakkar
BRITISH JOURNAL OF CANCER (2010)
Extracellular DNA traps promote thrombosis
Tobias A. Fuchs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Emerging risk stratification approaches to cancer-associated thrombosis: risk factors, biomarkers and a risk score
Gregory C. Connolly et al.
THROMBOSIS RESEARCH (2010)
Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism
David A. Manly et al.
THROMBOSIS RESEARCH (2010)
NF-κB Transcription Factor p50 Critically Regulates Tissue Factor in Deep Vein Thrombosis
Yi-Dan Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Assessing Risk of Venous Thromboembolism in the Patient With Cancer
Alok A. Khorana et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo
Grace M. Thomas et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Cancer-associated thrombosis: risk factors, candidate biomarkers and a risk model
Rohit Sud et al.
THROMBOSIS RESEARCH (2009)
Development and validation of a predictive model for chemotherapy-associated thrombosis
Alok A. Khorana et al.
BLOOD (2008)
Venous thrombosis in children with solid tumors
Amalia Schiavetti et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2008)
The Pivotal Role of Thrombin in Cancer Biology and Tumorigenesis
Kristen M. Snyder et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2008)
Microparticle-associated tissue factor activity: a link between cancer and thrombosis?
M. E. T. Tesselaar et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Interaction of histones with phospholipids - implications for the exposure of histones on apoptotic cells
Barbara G. Fuernrohr et al.
AUTOIMMUNITY (2007)
Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype
Mary Lynn Nierodzik et al.
CANCER CELL (2006)
Platelet aggregation-induced by caco-2 cells: Regulation by matrix metalloproteinase-2 and adenosine diphosphate
C Medina et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Incidence of venous thrombosis in a large cohort of 66 329 cancer patients:: results of a record linkage study
JW Blom et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Incidence of venous thromboembolism in patients hospitalized with cancer
PD Stein et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Ultrastructural damage in vascular endothelium in rats treated with paclitaxel and doxorubicin
Deniz Yamac et al.
ULTRASTRUCTURAL PATHOLOGY (2006)
Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study
AA Khorana et al.
CANCER (2005)
Significant effect of capecitabine on the pharmacokinetics and pharmacodynamics of warfarin in patients with cancer
R Camidge et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism
AYY Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Malignancies, prothrombotic mutations, and the risk of venous thrombosis
JW Blom et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells
JS Palumbo et al.
BLOOD (2005)
Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall
SM Day et al.
BLOOD (2005)
Membrane type-1 matrix metalloproteinase stimulates tumour cell-induced platelet aggregation: role of receptor glycoproteins
D Alonso-Escolano et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Thrombin induces neoangiogenesis in the chick chorioallantoic membrane
M Caunt et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin
S Falati et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
P-selectin and leukocyte microparticles are associated with venous thrombogenesis
DD Myers et al.
JOURNAL OF VASCULAR SURGERY (2003)
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
P Prandoni et al.
BLOOD (2002)
Platelet glycoprotein Ibα is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18)
DI Simon et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Risk factors for deep vein thrombosis and pulmonary embolism -: A population-based case-control study
JA Heit et al.
ARCHIVES OF INTERNAL MEDICINE (2000)